An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This research study is evaluating the effectiveness of topical sirolimus combined with
topical steroid therapy, as a possible treatment for oral cGVHD.